109 related articles for article (PubMed ID: 26707313)
1. Impact of Donor and Recipient Single Nucleotide Polymorphisms in Living Liver Donor Transplantation for Hepatitis C.
Miyaaki H; Ichikawa T; Taura N; Miuma S; Honda T; Shibata H; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
Transplant Proc; 2015 Dec; 47(10):2916-9. PubMed ID: 26707313
[TBL] [Abstract][Full Text] [Related]
2. Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C.
Dunn W; O'Neil M; Zhao J; Wu CH; Roberts B; Chakraborty S; Sherman C; Weaver B; Taylor R; Olson J; Olyaee M; Gilroy R; Schmitt T; Wan YJ; Weinman SA
Hepatology; 2014 Feb; 59(2):453-60. PubMed ID: 24123231
[TBL] [Abstract][Full Text] [Related]
3. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
[TBL] [Abstract][Full Text] [Related]
4. The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.
Kiatbumrung R; Chuaypen N; Payungporn S; Avihingsanon A; Tangkijvanich P
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2191-2197. PubMed ID: 30139224
[TBL] [Abstract][Full Text] [Related]
5. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Kiessling A; Yahyazadeh A; Trautwein C; Wasmuth H; Puhl G; Neuhaus P; Bahra M
J Gastroenterol Hepatol; 2013 Jan; 28(1):153-60. PubMed ID: 22989351
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
Patin E; Kutalik Z; Guergnon J; Bibert S; Nalpas B; Jouanguy E; Munteanu M; Bousquet L; Argiro L; Halfon P; Boland A; Müllhaupt B; Semela D; Dufour JF; Heim MH; Moradpour D; Cerny A; Malinverni R; Hirsch H; Martinetti G; Suppiah V; Stewart G; Booth DR; George J; Casanova JL; Bréchot C; Rice CM; Talal AH; Jacobson IM; Bourlière M; Theodorou I; Poynard T; Negro F; Pol S; Bochud PY; Abel L; ;
Gastroenterology; 2012 Nov; 143(5):1244-1252.e12. PubMed ID: 22841784
[TBL] [Abstract][Full Text] [Related]
7. Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation.
Chiu KW; Nakano T; Chen KD; Lin CC; Hu TH; Goto S; Chen CL
PLoS One; 2016; 11(6):e0156846. PubMed ID: 27275739
[TBL] [Abstract][Full Text] [Related]
8. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
10. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
Wali M; Harrison RF; Gow PJ; Mutimer D
Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
[TBL] [Abstract][Full Text] [Related]
11. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
15. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK
Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957
[TBL] [Abstract][Full Text] [Related]
16. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
17. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
18. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients.
Bader El Din NG; Farouk S; El-Shenawy R; Ibrahim MK; Dawood RM; Elhady MM; Salem AM; Zayed N; Khairy A; El Awady MK
World J Gastroenterol; 2016 Sep; 22(34):7767-77. PubMed ID: 27678360
[TBL] [Abstract][Full Text] [Related]
20. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
